Stage III Grade 3 Follicular Lymphoma [clinicaltrials_resource:77eb16c3f823885b53a2672c759091b2]
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma [clinicaltrials:NCT00003204]Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00003970]Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00010192]Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma [clinicaltrials:NCT00017381]clinicaltrials:NCT00049504Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma [clinicaltrials:NCT00077155]Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [clinicaltrials:NCT00078858]Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas [clinicaltrials:NCT00089271]Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [clinicaltrials:NCT00096005]Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [clinicaltrials:NCT00096161]Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00105001]Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [clinicaltrials:NCT00112593]Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function [clinicaltrials:NCT00118170]Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [clinicaltrials:NCT00275080]3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma [clinicaltrials:NCT00293345]Rituximab and Oblimersen in Treating Patients With Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma [clinicaltrials:NCT00301795]A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [clinicaltrials:NCT00343798]PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [clinicaltrials:NCT00348985]PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma [clinicaltrials:NCT00354185]Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease After Donor Stem Cell Transplant [clinicaltrials:NCT00408681]Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00489203]Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction [clinicaltrials:NCT00499811]Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery [clinicaltrials:NCT00608361]FAU in Treating Patients With Advanced Solid Tumors or Lymphoma [clinicaltrials:NCT00769288]Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant [clinicaltrials:NCT00795769]Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications [clinicaltrials:NCT00799461]Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders [clinicaltrials:NCT00856388]Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [clinicaltrials:NCT00891072]Genetically Engineered Lymphocyte Therapy in Treating Patients With B-Cell Leukemia or Lymphoma That is Resistant or Refractory to Chemotherapy [clinicaltrials:NCT01029366]Lenalidomide as Maintenance Therapy After Combination Chemotherapy With or Without Rituximab and Stem Cell Transplant in Treating Patients With Persistent or Recurrent Non-Hodgkin Lymphoma That is Resistant to Chemotherapy [clinicaltrials:NCT01035463]Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT01044745]clinicaltrials:NCT01045928Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [clinicaltrials:NCT01076270]Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells [clinicaltrials:NCT01097057]clinicaltrials:NCT01129193clinicaltrials:NCT01145495RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors [clinicaltrials:NCT01158274]clinicaltrials:NCT01159067Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas [clinicaltrials:NCT01193842]
condition [clinicaltrials_vocabulary:condition]
Stage III Grade 3 Follicular Lymphoma [clinicaltrials_resource:77eb16c3f823885b53a2672c759091b2]
Bio2RDF identifier
77eb16c3f823885b53a2672c759091b2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:77eb16c3f823885b53a2672c759091b2
identifier
clinicaltrials_resource:77eb16c3f823885b53a2672c759091b2
title
Stage III Grade 3 Follicular Lymphoma
@en
label
Stage III Grade 3 Follicular L ...... b16c3f823885b53a2672c759091b2]
@en